icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 13 Aug 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT)

A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT)

icon 2025-03-10
عنوان الدراسة
ational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT)
داعم الدراسة
Astrazeneca
دواء الدراسة
Ultomiris (Ravulizumab)
رقم بروتوكول الدراسة
ALX-NMO-50
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh) ,King Abdulaziz Medical City NG (Jeddah),King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
4